Sun, Aug 20, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index up 1.73% in July; (+5.86% YTD)

Wednesday, August 14, 2013
Opalesque Industry Update - Hedge funds gained 1.73% in July, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 5.86% year to date.

The Barclay Hedge Fund Index now has gains in six out of seven months in 2013 and positive returns in 13 of the past 14 months of trading.

“Tapering fears receded in July as the Fed and the ECB maintained their accommodative posture, helping equity and bond markets to rebound from June’s losses,” says Sol Waksman, founder and president of BarclayHedge.

“Positive economic news in the US and Europe bolstered investor confidence and helped to boost the MSCI World Index to a gain of more than 5 percent.”

All but one of Barclay’s 18 hedge fund strategies gained ground in July. The Barclay Healthcare & Biotechnology Index jumped 4.22%, Equity Long Bias gained 3.53%, the Technology Index was up 3.47%, Equity Long/Short gained 1.93%, and Distressed Securities added 1.78%.

The Equity Short Bias Index dropped another 4.50% in July. Equity Short Bias has five months of losses this year, and is down 19.59% after seven months in 2013. At this point, Short Bias is on track to surpass its record loss of 24.12% logged in 2012.

Four hedge fund strategies have recorded double-digit returns thus far in 2013. Healthcare & Biotechnology has gained 15.70% year to date, Pacific Rim Equities are up 13.76%, the Equity Long Bias Index has gained 12.26%, and Distressed Securities are up 10.01%.

The Barclay Fund of Funds Index was up 0.95% in July and has gained 4.25% year to date.

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: Albright Capital puts a value lens on emerging markets[more]

    Bailey McCann, Opalesque New York: Over the past decade, investors have steadily increased investments in emerging markets private funds. Allocations to the cohort have increased from $93 billion in December 2006 to $564 billion in September 2016, according to data from research firm Preqin. Howe

  2. Comment: "Long-Term Investing": What managing drawdown risk can do to your long-term returns[more]

    Matthias Knab, Opalesque: Real Investment Advice writes on Harvest Exchange: Last week, I was having lunch with a prospective portfolio management client discussing the curre

  3. Jasper Capital International joins Hedge Fund Standards Board[more]

    Komfie Manalo, Opalesque Asia: Diversified and systematic investment firm Jasper Capital International has become the second China-based signatory to the Hedge Fund Standards Board (HFSB), an organization that brings hedge fund managers and investors together to set standards for the hedge fund i

  4. Investing - Hedge-fund honchos including David Tepper are loading up on Alibaba, Billionaire hedge fund manager Stanley Druckenmiller is betting big on the Chinese consumer, Big-name U.S. hedge funds shed healthcare stocks during the rally in second-quarter, U.S. hedge funds bearish on FAANG stocks in second-quarter, Hedge fund titan Viking Global made a $680 million bet on scandal-plagued Wells Fargo[more]

    Hedge-fund honchos including David Tepper are loading up on Alibaba From CNBC.com: David Tepper's Appaloosa Management and three other he ge funds took new stakes in Chinese e-commerce giant Alibaba in the second quarter, according to the latest quarterly filings. Appaloosa disclos

  5. FinTech - Danger: Crowdfunding on the wrong platform could force you to go public[more]

    From LinkedIn.com: Some equity crowdfunding platforms are putting startups at serious risk. Working with a platform that doesn't structure your deal appropriately could jeopardize your ability to raise future capital or worse, force you to become a public reporting company. The emergence of eq